Advantage Alpha Capital Partners LP Aurinia Pharmaceuticals Inc. Transaction History
Advantage Alpha Capital Partners LP
- $337 Million
- Q2 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 24,079 shares of AUPH stock, worth $271,129. This represents 0.06% of its overall portfolio holdings.
Number of Shares
24,079Holding current value
$271,129% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
243Shares Held
62.4MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$113 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$104 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.7 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.6B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...